Table 1. Clinical characteristics of patients.
The five Y loss cases are highlighted. nd, not done; na, not available.
| Cohort 1 Patient | ER | PR | HER2 | Stage |
|---|---|---|---|---|
| 01 | + | + | − | IA |
| 02 | + | + | nd | IA |
| 03 | + | + | nd | IA |
| 04 | + | + | nd | IA |
| 05 | + | + | − | IA |
| 06 | + | + | nd | IA |
| 07 | + | Focally + | Weakly + | IIIC |
| 08 | + | + | nd | IIA |
| 09 | + | + | nd | IIA |
| 10 | + | + | Equivocal | IIB |
| 11 | + | − | − | IIIA |
| 12 | nd | nd | nd | IA |
| 13 | + | − | − | IIA |
| 14 | + | − | − | IB |
| 15 | na | na | na | na |
|
Cohort 2 Patient | ||||
| 01 | + | + | na | IIIB |
| 02 | + | nd | na | 1 |
| 03 | + | + | na | na |
| 04 | + | + | na | IIIB |
| 05 | nd | nd | na | DCIS |
| 06 | nd | nd | na | DCIS |
| 07 | + | + | + | IIIB |
| 08 | + | + | na | IIA |
| 09 | + | + | na | IIA |
| 10 | + | + | na | IA |
| 11 | + | + | na | IIB |
| 12 | na | na | na | IV |
| 13 | + | + | na | IIA |
| 14 | + | + | na | IA |
| 15 | + | + | na | IIA |
| 16 | + | − | na | IA |
| 17 | + | − | nd | IV |